Prospective Study in Pregnant Women With Hypercoagulopathy
NCT00215969 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2006-02-02
Summary
Pre-eclampsia is one of the most common causes of maternal and fetal morbidity and mortality. The aim of this study is to identify pregnant women at risk for pre-eclampsia or other cardiovascular complications at a very early state of the disease, and thereby improve the current method of screening.
Conditions
- Pre-Eclampsia
- Eclampsia
Sponsors & Collaborators
-
Department of Clinical Trials, Denmark
collaborator OTHER_GOV -
Loyola University
collaborator OTHER -
Hillerod Hospital, Denmark
lead OTHER
Principal Investigators
-
Anita S Andersen, MD
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-01-31
- Completion
- 2007-10-31
Countries
- Denmark
More Related Trials
-
Molecular Study of the Maternal-fetal Interface in Preeclampsia.
NCT06232668 ·Status: RECRUITING
-
Preeclampsia and Circulating Biomarkers
NCT02136667 ·Status: UNKNOWN
-
The Study of Cardiovascular Outcomes in Women With Preeclampsia Using Echocardiography: The SCOPE Study
NCT02357667 ·Status: COMPLETED
-
Left Ventricular and Endothelial Function in Preeclampsia
NCT00201500 ·Status: COMPLETED
-
Venous Thromboembolism in Pregnancy Study
NCT00856076 ·Status: UNKNOWN
-
Urine-plasminogen as a Predictor for Development Of Preeclampsia in Pregnant Women With Type 1 Diabetes Mellitus
NCT01821053 ·Status: COMPLETED
-
Sensitivity of Angiotensin II Type II Receptors in Women Following Preeclampsia
NCT05937841 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
TIPPS: Thrombophilia in Pregnancy Prophylaxis Study
NCT00967382 ·Status: COMPLETED ·Phase: PHASE3
-
Family Study on Preeclampsia
NCT00344162 ·Status: COMPLETED
-
LMWH to Prevent Preeclampsia and Fetal Growth Restriction
NCT00260520 ·Status: TERMINATED
-
Evaluation of Pre-dose and Post-dose Anti-factor Xa Levels With Enoxaparin Use During Pregnancy
NCT00319176 ·Status: COMPLETED
-
HOME: Home Monitoring of High-risk Pregnancies
NCT05763069 ·Status: ENROLLING_BY_INVITATION
-
Non-Invasive Preeclampsia Screening and Biobank
NCT06643741 ·Status: RECRUITING
-
Balance of Angiotensin II Receptors in Vessel Function After Preeclampsia
NCT06157580 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
State of Coagulation in Pre-eclampsia: Comparing Sonoclot Signature Analysis With Conventional and Specific Haemostasis Assays
NCT05625763 ·Status: UNKNOWN
-
First-trimester Prediction of Preeclampsia
NCT02189148 ·Status: COMPLETED
-
Characterization and Epigenetics of Post-Partum Preeclampsia
NCT02935556 ·Status: TERMINATED
-
Goal-Directed Therapy in Pregnant Women at High Risk of Developing Preeclampsia
NCT01351428 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Low Molecular Weight and Unfractionated Heparin in Pregnancy
NCT00721591 ·Status: COMPLETED
-
Precision Medicine for Prediction & Prevention of Early Pre-eclampsia
NCT04412681 ·Status: UNKNOWN ·Phase: NA
-
Low Weight Heparin prOphylaxis for Placental-Mediated Complications of PrEgnancy
NCT01388322 ·Status: COMPLETED ·Phase: PHASE3
-
THROmbinography in Pregnant Woman and in Vitro Action of Low Molecular Weight HEparin
NCT06575309 ·Status: RECRUITING
-
Disease Modification in Toxaemia of Pregnancy
NCT00175695 ·Status: COMPLETED
-
Improved Characterisation of Eclampsia
NCT05199558 ·Status: UNKNOWN
-
Prediction and Prevention of Preeclampsia by First Trimester Ultrasound
NCT01195441 ·Status: COMPLETED